An RNA Trans-Splicing Strategy to Rewrite mRNAs Implicated in Cardiomyopathy
Conferences
Fiflis, D; Benkert, A; Sewell, B; Clements, K; Asokan, A
Published in: MOLECULAR THERAPY
April 28, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2025
Volume
33
Issue
4
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Fiflis, D., Benkert, A., Sewell, B., Clements, K., & Asokan, A. (2025). An RNA Trans-Splicing Strategy to Rewrite mRNAs Implicated in Cardiomyopathy. In MOLECULAR THERAPY (Vol. 33).
Fiflis, David, Abigail Benkert, Beatrice Sewell, Katie Clements, and Aravind Asokan. “An RNA Trans-Splicing Strategy to Rewrite mRNAs Implicated in Cardiomyopathy.” In MOLECULAR THERAPY, Vol. 33, 2025.
Fiflis D, Benkert A, Sewell B, Clements K, Asokan A. An RNA Trans-Splicing Strategy to Rewrite mRNAs Implicated in Cardiomyopathy. In: MOLECULAR THERAPY. 2025.
Fiflis, David, et al. “An RNA Trans-Splicing Strategy to Rewrite mRNAs Implicated in Cardiomyopathy.” MOLECULAR THERAPY, vol. 33, no. 4, 2025.
Fiflis D, Benkert A, Sewell B, Clements K, Asokan A. An RNA Trans-Splicing Strategy to Rewrite mRNAs Implicated in Cardiomyopathy. MOLECULAR THERAPY. 2025.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2025
Volume
33
Issue
4
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics